| 
Mitochondrial
Toxicity/ Mitochondrial DNA (mtDNA)
Mitochondrial
Toxicity and Lipodystrophy Associated with Different NRTIs
2/16/07
Evidence
of Mitochondrial Toxicity in Fat and Peripheral Blood Mononuclear Cells
- 8/01/06
Therapeutic
Approaches to Combating Lipoatrophy: Do They Work? - 6/17/05
Study Finds
mtDNA in Blood Is Not a Reliable Marker of Clinical Mitochondrial Diseases
and Cannot Be Used in the Place of Tissue Biopsies - 6/01/05
Greater
and More Rapid Depletion of Mitochondrial DNA in Blood of Patients Treated
with Dual vs. Single NRTIs - 4/11/05
Evaluation
of 24-weeks of Peginterferon Alfa-2a (Pegasys) and Ribavirin Therapy in HIV-HCV
Coinfected Patients with Acute Hepatitis C - 1/26/05
Lipoatrophy
and Mitochondrial DNA Assays - 1/21/05
Lopinavir/Ritonavir
Plus Nevirapine as a Nucleoside-sparing Approach in Treatment-experienced HIV
Patients
- 1/12/05
Improvements
in Lipoatrophy, Mitochondrial DNA Levels and Fat Apoptosis after Replacing
Stavudine with Abacavir or Zidovudine
- 1/10/05
|